Arcturus Therapeutics (NASDAQ:ARCT) Issues Quarterly Earnings Results, Beats Estimates By $0.60 EPS
Arcturus Therapeutics (NASDAQ:ARCT - Get Free Report) announced its quarterly earnings results on Monday. The biotechnology company reported ($0.49) earnings per share (EPS) for the quarter, beating...